Adapting high-throughput screening methods and assays for biocontainment laboratories. - Wikidata - wikimedia - TriplyDB

Adapting high-throughput screening methods and assays for biocontainment laboratories.

Adapting high-throughput screening methods and assays for biocontainment laboratories.

http://www.wikidata.org/entity/Q30391971

about

Epigenetic assays for chemical biology and drug discovery.Mycobacterium tuberculosis High-Throughput Screening.

P2860

Q30358152-86E55A45-92E0-421B-888E-ABF517916405 Q36055844-CA1FA440-934B-4571-AF6A-7445D57B93BF

P2860

Adapting high-throughput screening methods and assays for biocontainment laboratories.

http://www.wikidata.org/entity/Q30391971

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@ast

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@en

type

label

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@ast

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@en

altLabel

Adapting high-throughput screening methods and assays for biocontainment laboratories

@en

prefLabel

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@ast

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@en

P1433

Q30391971-4115043C-394D-4497-93E4-A35D93CC12BE

P1476

Q30391971-929BAC31-15D1-4BAE-BAB6-A817326F9749

P2093

Q30391971-6405D43C-5FD4-4C3F-8ACE-DD80DB72D58F

Q30391971-678FCBCB-3FDF-4653-956F-AD895B828028

Q30391971-702A6D28-BB01-4227-8BD7-513C432DB34F

Q30391971-8D255B3B-BAAA-4C33-AC08-C43C45F0CA38

Q30391971-9BB3D86E-FDDA-4ACD-9315-AFED6EED77F7

Q30391971-9F391CC1-40A6-4AB7-896D-C6DB973B9CA4

Q30391971-A8D8235B-FC7C-4C7C-A2F1-B02008D0CFB8

Q30391971-D7E4DF8E-BB2D-415C-A361-E0F6375735DF

Q30391971-D81D38F8-77A4-41C6-B117-55B3945DCE12

P2860

Q30391971-04038F58-544A-458C-8452-F544E3F42EDE

Q30391971-0BEB0BC7-9DBE-4C46-B105-26171D60EA3C

Q30391971-15681B6D-FACB-4CD7-8F5D-10137F354CDB

Q30391971-18308A1B-EEDF-4490-BB6D-541A17833294

Q30391971-1BD5DB0C-33AE-4F19-ACA6-B1EEB3637301

Q30391971-22ABBEF1-8F74-4D4D-B40A-EF30E3505234

Q30391971-2592DB2B-67C1-4D3D-854D-75F4C02BA6FA

Q30391971-37FB556D-DA56-49F0-9A13-8C2BDBBD2197

Q30391971-39F7AFAE-661E-47F0-B2E1-2A8F7E4129E1

Q30391971-40FF16AE-F4E7-45AE-958F-980FE6B4DBE6

P304

Q30391971-333D2640-41E7-468E-86FC-C87AD66F1116

P31

Q30391971-7659A9BF-6186-428F-9E94-B5FE410BD1BC

P356

Q30391971-1D42A202-B2FF-4871-BE62-06276F6B7CDD

P407

Q30391971-F3AA07CA-99CB-43E8-96D2-E9705D6F9912

P433

Q30391971-D101508F-F256-48B0-8086-E30AA0AEA910

P478

Q30391971-99442F83-DB2A-42C7-9CEE-9B09529C2D44

P577

Q30391971-9E2F1258-A458-4FFB-BA7B-F1AC47875DEF

P698

Q30391971-66D85A54-B881-4392-849D-86E15CB8B8F7

P921

Q30391971-5919BFA3-CB34-48D1-B03E-FD25B4840F39

P932

Q30391971-4EEA0A58-B305-45BF-AFFB-C70CB8801FE9

P356

P1433

Assay and Drug Development Technologies

P1476

Adapting high-throughput screening methods and assays for biocontainment laboratories.

@en

P2093

Alexander Bukreyev

http://www.w3.org/2001/XMLSchema#string

Barry Rockx

http://www.w3.org/2001/XMLSchema#string

Bersabeh Tigabu

http://www.w3.org/2001/XMLSchema#string

E Lucile White

http://www.w3.org/2001/XMLSchema#string

James W LeDuc

http://www.w3.org/2001/XMLSchema#string

James W Noah

http://www.w3.org/2001/XMLSchema#string

Lynn Rasmussen

http://www.w3.org/2001/XMLSchema#string

Nichole Tower

http://www.w3.org/2001/XMLSchema#string

Robert Bostwick

http://www.w3.org/2001/XMLSchema#string

P2860

High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses

Shedding light on filovirus infection with high-content imaging

ML336: Development of Quinazolinone-Based Inhibitors Against Venezuelan Equine Encephalitis Virus (VEEV)

Assay development and high-throughput antiviral drug screening against Bluetongue virus

Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis

A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus.

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.

Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library.

High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).

Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.

P304

44-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ADT.2014.617

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25710545

http://www.w3.org/2001/XMLSchema#string

P921

High-throughput screening

P932

4340648

http://www.w3.org/2001/XMLSchema#string